We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Technology Improves Understanding of Complex Biological Samples

By LabMedica International staff writers
Posted on 15 May 2025

Tissues are composed of a complex mixture of various cell types, which complicates our understanding of their biological roles and the study of diseases. More...

Now, a multi-institutional team of researchers has developed a novel technology that enables the visualization of the distribution of components within a single cell, offering a significant advancement in understanding disease in complex biological samples.

t-SPESI (tapping-mode scanning probe electrospray ionization) is a technique that allows analysis of the spatial layout of molecules in a sample. This method involves taking multiple micro-samples from different areas of a cell and transferring them for mass spectrometry analysis, which provides precise identification of the chemical components present in those regions. The research team, led by The University of Osaka (Osaka, Japan), has developed a new t-SPESI unit that enables visualization of the sample in various modes. The technology also permits direct observation of the sampling process as the micro-samples are collected for mass spectrometry analysis. By modifying their previously developed t-SPESI system, the team positioned the analytical unit above an inverted fluorescence microscope. This setup allows for real-time observation of the sampling process and direct imaging of the sample itself. The sample can be imaged in different modes, enabling the detection of fluorescently tagged target molecules, identifying the distribution of features on the cell surface, and visualizing the locations of chemical components within the cell.

This technology can be used to map the distribution of intracellular lipids, which are fatty molecules that play critical roles in metabolic functions. Alterations in lipid distribution and function have been linked to various diseases. When applied to model cells, the technology allowed the researchers to observe lipids within individual cells using mass spectrometry imaging, directly visualize the cells through fluorescence microscopy, and determine the cell surface shape. The team also identified differences between various types of cells with distinct cellular compositions. This approach provides insight into the multidimensional molecular data of individual cells within diseased tissue samples. This groundbreaking technology promises to significantly enhance our ability to understand the processes behind disease development in complex biological samples, providing a clearer picture of the interactions and mixtures of cells present in tissue samples. This innovation is expected to contribute to the advancement of more effective therapies and diagnostic tools for a wide range of diseases.

Related Links:
The University of Osaka


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.